World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

MUCINOUS CYSTADENOCARCINOMA OF THE BREAST: A CASE REPORT AND REVIEW OF THE LITERATURE

Fatima-Zahra Kahouadji*, Dauphin Ntama, Soukaina Harrak, Saber Boutayeb, Ibrahim El Ghissassi, H. M’rabti and H. Errihani

ABSTRACT

Mucinous cystadenocarcinoma (MCA) is an unusual variant of primary breast carcinoma that bears a striking resemblance to MCAs of the ovary, pancreas and appendix. The metastatic lesion must be ruled out before the diagnosis can be determined. The differential diagnosis of MCA includes metastasis from other organs and cystic hypersecretory breast carcinoma. The incidence of breast mucinous cystadenocarcinoma is about 1-6% of primary breast cancers. It is usually diagnosed in postmenopausal women. The entity is usually triple-negative breast cancer. Herein we describe a case of 50-year-old female patient diagnosed histological with mucinous cystadenocarcinoma of the left breast. Immunohistochemistry profile showed triple negative and a high proliferation index. The biological behavior of MCA of the breast is reportedly favorable despite having a high proliferation index and triple-negative biomarker status. The importance of chemotherapy and radiotherapy is still debatable given the positive overall prognosis. The purpose of this study is to add to the body of literature by describing another instance of this uncommon case.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR